Pfizer, Sandoz Patent Spat Over Caduet Heads To Del.
By Nick Malinowski ( February 10, 2010, 1:48 PM EST) -- Pfizer Inc. has won its bid to transfer to Delaware federal court a patent infringement case over Sandoz Inc.'s abbreviated new drug application to manufacture a generic version of blood pressure and cholesterol reducer Caduet....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.